Oramed Pharmaceuticals Inc.
ORMPBiotechnology
$4.23+1.68%As of Oct 29vs prior close
- Market cap
- $173.1M
- From 52W high
- −20.79%
- EPS (LTM)
- $1.50
- Revenue (LTM)
- $2M
- Net margin
- 3202.50%
- Dividend yield
- –
Nomior Score
58
Steady ProfileTop 31% of the scored universe
Growth40
Quality46
Value—
Momentum95
Resilience47
Growth
+13.48%revenue a year over 9 fiscal years
YE16 $641KLTM $2M
Connections
Revenue to profitQ1 YE25
The operating loss was 225% of revenue.
Who owns it
1fund